Literature DB >> 22754095

Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses.

Uta Delling1, Katrin Lindner, Iris Ribitsch, Henriette Jülke, Walter Brehm.   

Abstract

The objective of this study was to compare bone marrow (BM) aspirates from the sternum and the tuber coxae of middle-aged horses. Bone marrow was obtained from the sternum and both tubera coxae of 12 healthy, 13-year-old geldings. Two different puncture techniques were used for the tuber coxae. The 2 syringes used for sternal sampling were evaluated separately. The mononuclear cell (MNC) fraction of the BM was isolated and the mesenchymal stem cells (MSCs) were culture-expanded. At the sternum, BM aspiration was always possible. Bone marrow aspiration at the tuber coxae required straight and deep needle penetration combined with high negative pressure. With this technique a median sample amount of 11.0 mL with large individual variation was obtained. A median of 3.06 × 10(6) MNC/mL BM (1st syringe) and 2.46 × 10(6) MNC/mL BM (2nd syringe) was isolated from sternal samples. In contrast, the tuber coxae yielded a median of 0.27 × 10(6) MNC/mL BM. The first passage yielded a median of 2.19 × 10(6) MSC (1st syringe) and 1.13 × 10(6) MSC (2nd syringe) from sternal samples, compared to a significantly lower median number of MSC from tuber coxae BM (0.06 × 10(6) MSC). The number of MNC and MSC obtainable from the BM aspirates taken from the tuber coxae is significantly lower than that obtained from the sternal BM aspirates. Autologous BM for the equine athlete is particularly clinically relevant at an advanced age. Based on our findings, the tuber coxae cannot be recommended for BM aspiration in middle-aged horses.

Entities:  

Mesh:

Year:  2012        PMID: 22754095      PMCID: PMC3244288     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

1.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

2.  Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols.

Authors:  C Bourzac; L C Smith; P Vincent; G Beauchamp; J-P Lavoie; S Laverty
Journal:  Equine Vet J       Date:  2010-09       Impact factor: 2.888

3.  Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.

Authors:  Catherine H Hackett; Maria Julia B F Flaminio; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

4.  Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.

Authors:  Simone Pacini; Silvia Spinabella; Luisa Trombi; Rita Fazzi; Sara Galimberti; Francesca Dini; Fabio Carlucci; Mario Petrini
Journal:  Tissue Eng       Date:  2007-12

5.  Performing bone marrow aspiration and biopsy in children: Recommended guidelines.

Authors:  Oussama Abla; Jeremy Friedman; John Doyle
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

6.  Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue.

Authors:  Chrisoula A Toupadakis; Alice Wong; Damian C Genetos; Whitney K Cheung; Dori L Borjesson; Gregory L Ferraro; Lawrence D Galuppo; J Kent Leach; Sean D Owens; Clare E Yellowley
Journal:  Am J Vet Res       Date:  2010-10       Impact factor: 1.156

7.  Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells.

Authors:  L A Fortier; A J Nixon; J Williams; C S Cable
Journal:  Am J Vet Res       Date:  1998-09       Impact factor: 1.156

8.  Bone marrow trephine biopsy.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

9.  Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis.

Authors:  P Horn; S Bork; A Diehlmann; T Walenda; V Eckstein; A D Ho; W Wagner
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

10.  Mesenchymal stem cell therapy for equine tendinopathy.

Authors:  Roger K W Smith
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

View more
  10 in total

1.  Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses.

Authors:  Garrett L Metcalf; Scott R McClure; Jesse M Hostetter; Rudy F Martinez; Chong Wang
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: are there differences?

Authors:  M K Adams; L R Goodrich; S Rao; F Olea-Popelka; N Phillips; J D Kisiday; C W McIlwraith
Journal:  Equine Vet J       Date:  2012-09-26       Impact factor: 2.888

3.  Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses.

Authors:  Miguel Espina; Henriette Jülke; Walter Brehm; Iris Ribitsch; Karsten Winter; Uta Delling
Journal:  PeerJ       Date:  2016-03-22       Impact factor: 2.984

4.  Combined Analysis of Endothelial, Hematopoietic, and Mesenchymal Stem Cell Compartments Shows Simultaneous but Independent Effects of Age and Heart Disease.

Authors:  Carine Ghem; Lucinara Dadda Dias; Roberto Tofani Sant'Anna; Renato A K Kalil; Melissa Markoski; Nance Beyer Nardi
Journal:  Stem Cells Int       Date:  2017-07-27       Impact factor: 5.443

5.  Sternal bone marrow derived equine multipotent mesenchymal stromal cells (MSCs): investigations considering the sampling site and the use of different culture media.

Authors:  Carina Eydt; Florian Geburek; Carmen Schröck; Nina Hambruch; Karl Rohn; Christiane Pfarrer; Carsten Staszyk
Journal:  Vet Med Sci       Date:  2016-06-20

6.  Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses.

Authors:  Ana Leda F Longhini; Tatiana E Salazar; Cristiano Vieira; Thao Trinh; Yaqian Duan; Louise M Pay; Sergio Li Calzi; Megan Losh; Nancy A Johnston; Huisheng Xie; Minsu Kim; Robert J Hunt; Mervin C Yoder; Domenico Santoro; Taralyn M McCarrel; Maria B Grant
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

7.  Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.

Authors:  Lauren V Schnabel; Lynn M Pezzanite; Douglas F Antczak; M Julia Bevilaqua Felippe; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2014-01-24       Impact factor: 6.832

8.  An Investigation of Equine Mesenchymal Stem Cell Characteristics from Different Harvest Sites: More Similar Than Not.

Authors:  Karla G Lombana; Laurie R Goodrich; Jennifer Nikki Phillips; John David Kisiday; Audrey Ruple-Czerniak; C Wayne McIlwraith
Journal:  Front Vet Sci       Date:  2015-12-07

Review 9.  Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

Authors:  Sophie Helen Bogers
Journal:  Front Vet Sci       Date:  2018-04-16

10.  Effectiveness of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate as Treatments for Chronic Hindlimb Proximal Suspensory Desmopathy.

Authors:  Grigorios Maleas; Mahmoud Mageed
Journal:  Front Vet Sci       Date:  2021-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.